"Uncertainty is a good thing. By combining data with clever filtering we get certainty and options from uncertainty." Dr. Levitt sees massive possibilities ahead. "The protein-folding problem that was a very difficult problem for 50 years, and drug design, are all being dealt with in this global, all-encompassing way. And I am personally very, very optimistic."
Michael Levitt, PhD
Stanford professor, a member of Insilico Medicine's Scientific Advisory Board, won the Nobel Prize in Chemistry in 2013 for his groundbreaking work in protein structure and protein folding using computer modeling.